NCT07049094View on ClinicalTrials.gov

The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

June 25, 2027

Study Completion Date

December 31, 2027

Conditions
Brain Tumor AdultCerebrovascular Disease
Interventions
DRUG

scalp nerve block with 0.25% hydrochloride bupivacaine and 0.67% bupivacaine liposome solution

Using 0.25% hydrochloride bupivacaine and 0.67% bupivacaine liposome solution for scalp nerve block

DRUG

scalp nerve block with 0.50% hydrochloride bupivacaine

Using 0.50% hydrochloride bupivacaine for scalp nerve block

Trial Locations (1)

310000

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER